Transamerica Financial Advisors Inc. Acquires Shares of 8,752 Aflac Incorporated (NYSE:AFL)

Transamerica Financial Advisors Inc. bought a new position in Aflac Incorporated (NYSE:AFL - Free Report) in the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The firm bought 8,752 shares of the financial services provider's stock, valued at approximately $979,000.

A number of other large investors have also recently made changes to their positions in the company. Y.D. More Investments Ltd bought a new stake in Aflac in the second quarter worth about $25,000. Darwin Wealth Management LLC bought a new stake in shares of Aflac during the 3rd quarter worth approximately $34,000. Covestor Ltd lifted its stake in shares of Aflac by 41.8% during the 3rd quarter. Covestor Ltd now owns 363 shares of the financial services provider's stock worth $41,000 after acquiring an additional 107 shares during the last quarter. Kennebec Savings Bank purchased a new position in Aflac during the 3rd quarter valued at $45,000. Finally, Catalyst Capital Advisors LLC bought a new position in Aflac in the 3rd quarter valued at $51,000. 67.44% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

A number of brokerages have recently issued reports on AFL. Truist Financial boosted their target price on shares of Aflac from $100.00 to $105.00 and gave the company a "hold" rating in a research note on Friday, November 1st. TD Cowen started coverage on shares of Aflac in a research report on Wednesday, October 9th. They issued a "hold" rating and a $102.00 price objective for the company. Piper Sandler raised their target price on shares of Aflac from $114.00 to $122.00 and gave the stock an "overweight" rating in a research report on Wednesday, October 2nd. Bank of America boosted their price target on Aflac from $115.00 to $124.00 and gave the company a "buy" rating in a report on Thursday, October 10th. Finally, Evercore ISI increased their price objective on Aflac from $84.00 to $90.00 and gave the stock an "underperform" rating in a research note on Thursday, September 26th. Three equities research analysts have rated the stock with a sell rating, ten have given a hold rating and three have assigned a buy rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of "Hold" and an average price target of $97.93.

Aflac Stock Up 0.7 %

Shares of Aflac stock opened at $114.01 on Wednesday. The company has a quick ratio of 0.08, a current ratio of 0.08 and a debt-to-equity ratio of 0.32. The company has a market cap of $63.34 billion, a P/E ratio of 17.17, a PEG ratio of 2.17 and a beta of 0.96. The firm's 50 day moving average price is $110.88 and its 200-day moving average price is $101.05. Aflac Incorporated has a 52-week low of $75.07 and a 52-week high of $115.50.

Aflac (NYSE:AFL - Get Free Report) last released its quarterly earnings results on Wednesday, October 30th. The financial services provider reported $2.16 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.69 by $0.47. Aflac had a net margin of 22.02% and a return on equity of 16.34%. The business had revenue of $2.95 billion for the quarter, compared to analyst estimates of $4.30 billion. During the same period in the previous year, the company earned $1.84 earnings per share. The business's revenue for the quarter was down 40.4% on a year-over-year basis. On average, sell-side analysts predict that Aflac Incorporated will post 7.22 EPS for the current fiscal year.

Aflac Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Monday, December 2nd. Shareholders of record on Wednesday, November 20th will be paid a $0.50 dividend. This represents a $2.00 dividend on an annualized basis and a yield of 1.75%. The ex-dividend date is Wednesday, November 20th. Aflac's dividend payout ratio (DPR) is presently 30.12%.

Aflac Profile

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.